Cosmo Feilding Mellen
Directeur Général chez Beckley Canopy Therapeutics Ltd.
Postes actifs de Cosmo Feilding Mellen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Beckley Canopy Therapeutics Ltd.
 Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
Beckley Psytech Ltd.
 Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Directeur/Membre du Conseil | 01/01/1998 | - |
| Directeur Général | 01/01/1998 | - | |
| Fondateur | 01/01/1998 | - |
Historique de carrière de Cosmo Feilding Mellen
Statistiques
Internationale
| Royaume-Uni | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Beckley Canopy Therapeutics Ltd.
Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Commercial Services |
Beckley Psytech Ltd.
Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Cosmo Feilding Mellen
- Expérience
